首页> 外文期刊>Российский физиологический журнал >Dependence of myocardium injury on extracellular K+ concentration during calcium paradox
【24h】

Dependence of myocardium injury on extracellular K+ concentration during calcium paradox

机译:心肌损伤对钙悖论细胞外K +浓度的依赖性

获取原文
获取原文并翻译 | 示例
       

摘要

It is well-known that the first stage of the calcium paradox involves decreasing of Na+ gradient. The decreased sodium gradient is a cause of activation of the Na(+)-Ca+ exchange and formation of cardiac injury during the calcium repletion. Potassium ions are natural extracellular activators of Na(+)-pump. It has been shown that heart perfusion by Ca(2+)-free medium evoked extrusion from cells of hydrophilic amino acids whose transport-depends on sodium gradient. The heart reperdusion with Ca(2+)-containing agent leads to myofibrillar contracture and extensive myoglobin release. The simultaneous events are: elevation in tissue water contents, decreasing of intracellular concentration of adeninnucleotides, uncoupling of oxidation and phosphorylation in mitochondria. The decreasing of K+ level to 0.5 mM exacerbates myocardial damage during the calcium paradox, despite absence of myocardial contracture. The elevation of K+ (to 10 mM or 20 mM) attenuated the calcium paradox development in the heart. The elevated K+ concentration protected isolated heart from extensive myoglobin release, development of myocardial contracture. The high K+ concentrations alleviate mitochondrial damage and elevate contents of adeninnucleotide in the tissue. The positive effect of the elevated K+ concentration can be completely blocked by strophanthine, the selective Na+, K(+)-pumb blocker.
机译:众所周知,钙悖论的第一阶段涉及降低Na +梯度。降低的梯度是活化Na(+) - Ca +交换和心脏损伤在钙的原因的原因。钾离子是Na(+)泵的天然细胞外激活剂。已经表明,通过Ca(2 +)的心脏灌注 - 从其运输 - 取决于梯度的亲水性氨基酸细胞中诱发挤出的挤出。含Ca(2 +)的药剂的心脏再抑制导致肌原纤维挛缩和广泛的肌球蛋白释放。同时事件是:组织水含量的升高,降低细胞内浓度的腺嘌呤核苷酸,线粒体氧化的抗耦合和磷酸化。尽管没有心肌挛缩,但k +水平的降低至0.5mm加剧了钙悖论中的心肌损伤。 K +(10mm或20mm)的升高减弱了心脏的钙悖论。升高的K +浓度保护了来自广泛的肌球蛋白释放,开发心肌挛缩的孤立心脏。高k +浓度减轻线粒体损伤并提高组织中腺苷含量。升高的K +浓度的正效应可以通过链孔,选择性Na +,K(+) - 钢板阻滞剂完全阻塞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号